E-drug: Re: US compulsory licensing proposal for medicines (contd)
-------------------------------------------------------------------------
John Urquhart has distorted what I had to say about the study on drug
development costs from Tufts University. I did not say it was not a
credible study I pointed out that its results just applied to about 25%
of the NCEs introduced annually onto the American market.
--
Joel Lexchin MD
121 Walmer Rd.
Toronto, Ontario
Canada M5R 2X8
T: +416-964-7186
F: +416-923-9515
e mail: joel.lexchin@utoronto.ca
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.